[1]
Gärtner, F. et al. 2022. Characteristics and survival of patients with non-small cell lung cancer treated with immune-checkpoint inhibitors in the real-world: experiences from Bergen, Norway. Acta Oncologica. 61, 7 (Jul. 2022), 814–818. DOI:https://doi.org/10.1080/0284186X.2022.2068969.